What we do
We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
Our world-leading Consumer Healthcare business combines science and consumer insights to create innovative everyday healthcare brands that consumers trust and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
We have a significant global presence with commercial operations in more than 150 countries, a network of 86 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China.
In March 2015, we completed a 3-part transaction with Novartis which reshapes our business.
We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. By substantially strengthening Vaccines and Consumer Healthcare, we can deliver far-reaching benefits to patients and consumers, and further value to shareholders.
Consumer Healthcare Pakistan
Consumer Healthcare business develops a range of products in the areas of: Pain Relief, Respiratory, Oral Health, Nutrition/Gastrointestinal and Skin Health, these include globally recognised brands such as Panadol, Sensodyne, Eno and Horlicks.
For more information, please check our Brands.
Our strategy is to combine our strengths and competences to become the leading FMCH Company driven by science and values.
GSK Consumer Healthcare Pakistan’s aim is to build strong relationship with retailers, healthcare professionals and shoppers in the most professional and ethical manner; by keeping our consumers at heart and building category defining brands we aim to create trust and work towards continuous innovation to product the best quality products for our consumers.
Our business is built on science and this research heritage contributes to the development of our Consumer Healthcare products, giving us a unique advantage over our competition.
Today, we are using science to speed up the time to develop new product innovations and make them more accessible to the people who need them. We develop benefits that our consumers value which ultimately grows our business.
At the same time, we continue to ensure we meet all regulatory requirements for testing, approval, manufacturing, labelling and marketing of our products.
Our values and expectations are at the heart of everything we do and everyone at GSK is focused on our three long-term priorities. Innovation, Performance and Trust.
Our values and expectations help us focus on behaviours which make the biggest difference to us achieving our goal and building a culture aligned to Innovation, Performance and Trust. Our values remain our source of pride and the foundation of who we are: patient focus, transparency, respect and integrity.
From 2018 we have four new expectations which sit alongside our values: courage, accountability, development and teamwork. Together, our values and expectations guide our everyday actions and decision-making.